StreetWatch: Nuvectis Pharma Eyes $9.8 Billion Oral PNH Market With Late-Stage NXP100 Backed by Strong Positive Phase 3 Data

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/5/2026

1. ZS
2. LULU
3. IOT
4. SPY
5. PATH
6. DOCU
7. ASAN
8. NVDA
9. GWRE
10. CIEN

Go back to StreetWatch: Nuvectis Pharma Eyes $9.8 Billion Oral PNH Market With Late-Stage NXP100 Backed by Strong Positive Phase 3 Data
(NASDAQ: NVCT) Delayed: 24.49 +0.12 (0.49%)
Previous Close $24.37    52 Week High $ 
Open $24.00    52 Week Low $ 
Day High $25.19    P/E N/A 
Day Low $23.96    EPS $ 
Volume 117,166